VENTYX BIOSCIENCES INC. - COMMON STOCK

Ventyx Biosciences Announces Completion of Enrollment of the Phase 2 Trial of VTX002 in Ulcerative Colitis and the Phase 2 Trial of VTX958 in Plaque Psoriasis

07 6月 2023 04:00:00 条件 Nasdaq GlobeNewswire

Ventyx Biosciences to Participate in Two Upcoming Investor Conferences

31 5月 2023 05:00:01 条件 Nasdaq GlobeNewswire

Ventyx Biosciences Reports First Quarter 2023 Financial Results and Highlights Recent Corporate Progress

11 5月 2023 13:01:00 条件 Nasdaq GlobeNewswire

Ventyx Biosciences to Report First Quarter 2023 Financial Results on May 11, 2023

04 5月 2023 13:05:01 条件 Nasdaq GlobeNewswire

Ventyx Biosciences to Participate in the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference

24 3月 2023 05:00:00 条件 Nasdaq GlobeNewswire

Ventyx Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Corporate Progress

23 3月 2023 13:01:00 条件 Nasdaq GlobeNewswire

Ventyx Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023

15 3月 2023 13:05:01 条件 Nasdaq GlobeNewswire

Ventyx Biosciences Provides Update on Silicon Valley Bank Financial Exposure

11 3月 2023 10:21:31 条件 Nasdaq GlobeNewswire

Ventyx Biosciences to Participate in Three Upcoming Investor Conferences

28 2月 2023 05:00:03 条件 Nasdaq GlobeNewswire

Ventyx Biosciences Announces Pipeline Updates and Highlights Strategic Priorities at Investor R&D Day

26 1月 2023 05:00:01 条件 Nasdaq GlobeNewswire

Ventyx Biosciences Appoints Allison J. Hulme, Ph.D. and Onaiza Cadoret-Manier to its Board of Directors

12 1月 2023 05:00:00 条件 Nasdaq GlobeNewswire

Ventyx Biosciences to Host R&D Event on January 26, 2023

05 1月 2023 05:00:01 条件 Nasdaq GlobeNewswire

Ventyx Biosciences Announces Dosing of the First Patient in the Phase 2 SERENITY Trial of VTX958 for the Treatment of Moderate to Severe Plaque Psoriasis

01 12月 2022 13:05:00 条件 Nasdaq GlobeNewswire

Ventyx Biosciences to Participate in Two Upcoming Investor Conferences

22 11月 2022 05:00:02 条件 Nasdaq GlobeNewswire

Ventyx Biosciences Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress

03 11月 2022 13:01:01 条件 Nasdaq GlobeNewswire

Ventyx Biosciences to Report Third Quarter 2022 Financial Results on November 3, 2022

27 10月 2022 13:05:01 条件 Nasdaq GlobeNewswire

Ventyx Biosciences to Participate in Three Upcoming Investor Conferences

27 10月 2022 06:00:01 条件 Nasdaq GlobeNewswire

Ventyx Biosciences Announces $176.6 Million Private Placement of Common Stock

19 9月 2022 05:00:00 条件 Nasdaq GlobeNewswire

Ventyx Biosciences to Participate in Two Upcoming Investor Conferences

29 8月 2022 13:05:00 条件 Nasdaq GlobeNewswire

Ventyx Biosciences Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Progress

15 8月 2022 13:05:01 条件 Nasdaq GlobeNewswire